EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Occurrence of comorbid diseases in patients after COVID-19

Umida Kamilova, Akbal Ermekbaeva, Nuriddin Nuritdinov, Abror Khamraev, Gulnoza Zakirova

Journal of Medicine and Life · 2023

DOI: 10.25122/jml-2022-0168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicine and Life, 2023. Verfasst von Umida Kamilova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Therapy, Tashkent Medical Academy, Tashkent, Uzbekistan. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, COVID-19, Heart Failure, Hypertension. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic has highlighted the potential impact of this disease on cardiovascular morbidity and mortality. Patients with established cardiovascular (CV) disease are at increased risk of severe infection and hospital-acquired adverse outcomes. This study aimed to investigate the prevalence and characteristics of comorbidities in COVID-19 patients. We analyzed data from 220 patients who previously contracted COVID-19. Statistical analysis was performed using SPSS software. The average age of the patients was 54.6 ± 11.4 years, and arterial hypertension (AH) was the most common comorbidity, affecting 55% of patients. Obesity was observed in one-third of patients, while coronary heart disease (CHD) and coronary heart failure (CHF) were reported in 17.7% and 11.8% of patients, respectively. Chronic kidney disease (CKD), atrial fibrillation (AF), and obstructive pulmonary disease (COPD) were less common. Cardiovascular diseases, particularly AH, were the most frequent comorbidities in COVID-19 patients. Understanding the prevalence and characteristics of comorbidities in COVID-19 patients is crucial for developing appropriate management strategies and improving clinical outcomes. Our findings highlight the importance of identifying and managing comorbidities in COVID-19 patients to reduce the risk of severe COVID-19 and improve clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveCOVID-19Heart FailureHypertensionCardiovascular DiseasesHumansAdultMiddle AgedAgedPandemicsRisk FactorsComorbidity

Stichwörter der Autor:innen

AF – atrial fibrillationAH – Arterial hypertensionCHD – coronary heart diseaseCHF – chronic heart failureCKD – chronic kidney diseaseCOPD – chronic obstructive pulmonary diseaseCOVID-19DM – diabetes mellituscomorbidityrisk factors

Autor:innen und Institutionen

  • Department of Therapy, Tashkent Medical Academy, Tashkent, Uzbekistan.
  • Department of Cardiology, Republican Specialized Scientific and Practical Medical Center of Therapy and Medical Rehabilitation, Tashkent, Uzbekistan.

Zitieren

APA

Kamilova, U., Ermekbaeva, A., Nuritdinov, N., Khamraev, A., & Zakirova, G. (2023). Occurrence of comorbid diseases in patients after COVID-19. Journal of Medicine and Life. https://doi.org/10.25122/jml-2022-0168

Vancouver

Kamilova U, Ermekbaeva A, Nuritdinov N, Khamraev A, Zakirova G. Occurrence of comorbid diseases in patients after COVID-19. Journal of Medicine and Life. 2023. doi:10.25122/jml-2022-0168

BibTeX
@article{Kamilova2023,
  author = {Kamilova, Umida and Ermekbaeva, Akbal and Nuritdinov, Nuriddin and Khamraev, Abror and Zakirova, Gulnoza},
  title = {Occurrence of comorbid diseases in patients after COVID-19},
  journal = {Journal of Medicine and Life},
  year = {2023},
  doi = {10.25122/jml-2022-0168}
}
Kostenlos starten →